Dr. Gian Nutal Schädli
Dr. Gian Nutal Schädli
Staff of Professorship for Biomechanics
Additional information
Research area
Gian Nutal Schädli, PhD, is an Established Researcher at ETH Zurich and the CEO and co-founder of CompagOs AG, a deep-tech startup dedicated to transforming bone health through diagnostics. With a background in Mechanical Engineering and a PhD in Bone Tissue Engineering from ETH Zurich, Gian has developed innovative methods for studying engineered bone tissue and bioprinted organoids. He uses dynamic compression bioreactor devices, which simulate physiological loading in bone and employs advanced imaging techniques to analyze their microstructure. His work underpins CompagOs’ flagship product, Bon3OID™, a highly mineralized bone model designed to enable the early detection of bone metastases in advanced cancer patients.
An entrepreneurial leader, Gian has been awarded an iPostdoc Fellowship by Personalized Health and Related Technologies (PHRT), a strategic focus domain of ETH Zurich. Together with the CompagOs team, he won funding from Venture Kick, a three-stage startup competition. His leadership style fosters innovation and collaboration, bridging cutting-edge research with real-world clinical applications. Gian’s vision is to enhance patient outcomes and reduce healthcare costs through scalable technologies that drive innovation in diagnostics and drug development.
Gian Nutal Schädli is a Postdoc and Project Leader at the Laboratory of Bone Biomechanics. He studied Mechanical Engineering at ETH Zurich and received his BSc as well as MSc degrees in 2013 and 2015; he succesfully defended his PhD Thesis in May 2021 on a framework for time-lapsed micro-CT imaging of nanocomposite scaffolds in dynamic compression bioreactors.